Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Distinct Micro-RNA profiles are associated with severity of hepatitis C virus recurrence and acute cellular rejection after liver transplant


ABSTRACT: Recurrent hepatitis C virus (rHCV) is universal post-liver transplantation (LT), with accelerated fibrosis rates compared to non-transplanted patients. rHCV is associated with increased mortality and morbidity post-transplant and is a leading indication for re-transplantation. We hypothesized that miRNA expression profiles from liver grafts can distinguish severity of HCV recurrence and differentiate this from acute cellular rejection (ACR). Methods Using microarrays, we characterized global microRNA (miRNA) expression from patients with slow HCV fibrosis progression (F<2 Ishak), fast HCV fibrosis progression (FM-bM-^IM-%2 Ishak), ACR and non-HCV transplanted patients. Selected miRNA were analysed by quantitative PCR (qPCR) using both liver tissue and serum samples. Results We demonstrated changes in miRNA expression in patients with slow HCV fibrosis progression that were anti-fibrogenic, anti-angiogenic and anti-inflammatory in comparison to patients with fast HCV fibrosis progression. miRNA-146a, miRNA-19a, miRNA- 20a and miRNA-let-7e expression were increased in the slow HCV fibrosis progression group. In addition, comparison of patients with fast HCV progression against patients with ACR identified pro-fibrogenic pathways. qPCR analysis on liver tissue and serum confirmed the up-regulation of miRNAs in the slow HCV fibrosis progression group. Conclusion We demonstrate specific miRNA expression signatures that distinguish rate of progression of HCV recurrence and ACR post M-bM-^@M-^Sliver transplantation. Pathway analysis indicates that specific miRNA may play a regulatory role in these processes. The miRNAs identified may act as potential biomarkers for HCV recurrence post-LT and help distinguish between ACR and recurrent HCV. We compared 29 patients in total; 11 patients with slow HCV fibrosis progression, 9 patients with fast HCV fibrosis progression, 5 patients with acute cellular rejection and 4 HCV negative patients with normal liver histology that acted as controls. RNA was extracted from archived histology samples of the RG and NRG and miRNA expression was analysed using the affymetrix Genechip miRNA 2.0 assays.

ORGANISM(S): Homo sapiens

SUBMITTER: siamak salehi 

PROVIDER: E-GEOD-40113 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation.

Joshi Deepak D   Salehi Siamak S   Brereton Helen H   Arno Matthew M   Quaglia Alberto A   Heaton Nigel N   O'Grady John J   Agarwal Kosh K   Aluvihare Varuna V  

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20130322 4


Recurrent hepatitis C virus (HCV) infection is associated with accelerated fibrosis rates after liver transplantation (LT) and is the leading cause of graft failure. Furthermore, distinguishing recurrent HCV from acute cellular rejection (ACR) can be problematic, and this can lead to inappropriate treatments and adverse outcomes. We hypothesized that intragraft microRNA (miRNA) expression profiles could distinguish the severity of recurrent HCV and differentiate recurrent HCV from ACR. We establ  ...[more]

Similar Datasets

2013-09-17 | GSE40113 | GEO
2020-09-10 | GSE154055 | GEO
2012-06-14 | E-GEOD-38226 | biostudies-arrayexpress
2023-03-11 | PXD024846 | Pride
2009-08-05 | GSE13440 | GEO
2018-04-09 | PXD009007 | Pride
2008-06-15 | E-GEOD-7741 | biostudies-arrayexpress
2012-02-10 | E-GEOD-34798 | biostudies-arrayexpress
2010-05-15 | E-GEOD-13440 | biostudies-arrayexpress
2014-08-22 | E-GEOD-54100 | biostudies-arrayexpress